Inhibition of CYP1A1 enzyme activity in mouse hepatoma cell culture by soybean isoflavones

被引:34
|
作者
Shertzer, HG
Puga, A
Chang, CY
Smith, P
Nebert, DW
Setchell, KDR
Dalton, TP
机构
[1] Univ Cincinnati, Med Ctr, Dept Environm Hlth, Cincinnati, OH 45267 USA
[2] Univ Cincinnati, Med Ctr, Ctr Environm Genet, Cincinnati, OH 45267 USA
[3] Univ Cincinnati, Med Ctr, Childrens Hosp, Res Fdn,Dept Pediat, Cincinnati, OH 45229 USA
关键词
CYP1A1; daidzein; genistein; isoflavones; soybeans; TCDD;
D O I
10.1016/S0009-2797(99)00121-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The mechanisms by which soybean- and soybean isoflavone-enriched diets inhibit carcinogenesis are not known. We found that the isoflavones genistin and daidzin, and their respective aglucone forms daidzein and genistein, block 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD; dioxin)-induced CYP1A1 enzyme activity. This inhibition is correlated with the capacity of the isoflavones to prevent CYP1A1-mediated covalent binding of benzo[a]pyrene (BaP) metabolites to DNA. We further evaluated daidzein and genistein, believed to be the active forms of the isoflavones, for the mechanism of the inhibitory process. Although daidzein and genistein appear structurally similar to known aromatic hydrocarbon receptor (AHR) agonists and antagonists, gel mobility shift assays indicated that the isoflavones do not inhibit dioxin-induced activation of the AHR or the accumulation of CYP1A1 mRNA, suggesting that the isoflavones do not act at the transcriptional level. We therefore evaluated the isoflavones for direct effects on the CYP1A1 enzyme. Daidzein and genistein are non-competitive with the CYP1A1 substrate BaP for microsomal BaP hydroxylation, with apparent K-1 values of 325 mu M and 140 mu M, respectively. The extent of CYP1A1 inhibition increases with time of preincubation at 37 degrees C, but not at 4 degrees C, in the presence of isoflavone pins NADPH; after 60 min preincubation the inhibition remains non-competitive, with apparent K-1 values of 55 mu M and 50 mu M, respectively. Inhibition is neither prevented nor reversed by the thiol antioxidant dithiothreitol, nor by the iron chelator deferoxamine. Repeated washing of the microsomes does not reverse the inhibition. The dependency on NADPH, temperature and time for inhibition of CYP1A1 suggests that metabolism of either isoflavone or molecular oxygen to reactive species is required. Isoflavone-mediated inhibition of CYP1A1 activity may contribute to the mechanism by which these soybean isoflavones protect against carcinogenesis. (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:31 / 49
页数:19
相关论文
共 50 条
  • [41] Changes of CYP1A1, GST, and ALDH3 enzymes in hepatoma cell lines undergoing enhanced lipid peroxidation
    Bassi, AM
    Ledda, S
    Penco, S
    Menini, S
    Muzio, G
    Canuto, R
    Ferro, M
    FREE RADICAL BIOLOGY AND MEDICINE, 2000, 29 (11) : 1186 - 1196
  • [42] DIETARY ELLAGIC ACID INHIBITS THE ENZYMATIC-ACTIVITY OF CYP1A1 WITHOUT ALTERING HEPATIC CONCENTRATIONS OF CYP1A1 OR CYP1A1 MESSENGER-RNA (VOL 201, PG 1477, 1994)
    BARCH, DH
    RUNDHAUGEN, LM
    THOMAS, PE
    KARDOS, P
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 207 (03) : 1058 - 1058
  • [43] Soy Isoflavones, CYP1A1, CYP1B1, and COMT Polymorphisms, and Breast Cancer: A Case-Control Study in Southwestern China
    Wang, Qiong
    Li, Hui
    Tao, Ping
    Wang, Yuan-Ping
    Yuan, Ping
    Yang, Chun-Xia
    Li, Jia-Yuan
    Yang, Fei
    Lee, Hui
    Huang, Yuan
    DNA AND CELL BIOLOGY, 2011, 30 (08) : 585 - 595
  • [44] Inhibition of procarcinogen-bioactivating human CYP1A1, CYP1A2 and CYP1B1 enzymes by melatonin
    Chang, Thomas K. H.
    Chen, Jie
    Yang, Guixiang
    Yeung, Eugene Y. H.
    JOURNAL OF PINEAL RESEARCH, 2010, 48 (01) : 55 - 64
  • [45] INCREASE OF CYP1A1 MESSENGER-RNA AND AHH ACTIVITY BY INHIBITORS OF EITHER PROTEIN OR RNA-SYNTHESIS IN MOUSE HEPATOCYTES IN PRIMARY CULTURE
    NEMOTO, N
    SAKURAI, J
    CARCINOGENESIS, 1991, 12 (11) : 2115 - 2121
  • [46] Identification of factors that controls the CYP1A1 background activity in vitro
    Öberg, M
    Bergander, L
    Häkansson, H
    Rannug, U
    Rannug, A
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2004, 197 (03) : 216 - 216
  • [47] Mechanism-based Inhibition of CYP1A1 and CYP3A4 by the Furanocoumarin Chalepensin
    Ueng, Yune-Fang
    Chen, Chien-Chih
    Yamazaki, Hiroshi
    Kiyotani, Kazuma
    Chang, Yu-Ping
    Lo, Wei-Shang
    Li, Ding-Tzai
    Tsai, Pei-Lun
    DRUG METABOLISM AND PHARMACOKINETICS, 2013, 28 (03) : 229 - 238
  • [48] RAT CYP1A1 NEGATIVE REGULATORY ELEMENT - BIOLOGICAL-ACTIVITY AND INTERACTION WITH A PROTEIN FROM LIVER AND HEPATOMA-CELLS
    STERLING, K
    WEAVER, J
    HO, KL
    XU, LC
    BRESNICK, E
    MOLECULAR PHARMACOLOGY, 1993, 44 (03) : 560 - 568
  • [49] Transcriptional and posttranscriptional regulation of CYP1A1 by vanadium in human hepatoma HepG2 cells
    Ghada Abdelhamid
    Anwar Anwar-Mohamed
    Osama A. Badary
    Adel A. Moustafa
    Ayman O.S. El-Kadi
    Cell Biology and Toxicology, 2010, 26 : 421 - 434
  • [50] Harman induces CYP1A1 enzyme through an aryl hydrocarbon receptor mechanism
    El Gendy, Mohamed A. M.
    El-Kadi, Ayman U. S.
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2010, 249 (01) : 55 - 64